Using immune cells to deliver anti-cancer drugs

Using immune cells to deliver anti-cancer drugs Date: January 3, 2017 | Source: Penn State Materials Research Institute | See Original Here Summary: Biomedical engineers have created a smart, targeted drug delivery system using immune cells to attack cancers. Artist's conception of nanoparticle-carrying immune cells that target tumors and release drug-loaded nanoparticles for cancer treatment.…
Continue Reading »

Genetic complexity of cancer cells within the same tumor

Genetic complexity of cancer cells within the same tumor Pioneering research identifies more than 2,000 mutations and illustrates treatment challenges Date: December 28, 2016 | Source: Cedars-Sinai Medical Center | See Original HereSummary: A new study dramatically illustrates the complexity of cancer by identifying more than 2,000 genetic mutations in tissue samples of esophageal tumors. The findings reveal that even…
Continue Reading »

Illuminating cancer: Researchers invent a pH threshold sensor to improve cancer surgery

Illuminating cancer: Researchers invent a pH threshold sensor to improve cancer surgery Date: December 20, 2016 Source: UT Southwestern Medical Center Summary: Researchers have invented a transistor-like threshold sensor that can illuminate cancer tissue, helping surgeons more accurately distinguish cancerous from normal tissue. See Original Here Dr. Darab Syner (left) and Dr. Jinming Gao (right)…
Continue Reading »

One Obstacle to Curing Cancer: Patient Data Isn’t Shared

One Obstacle to Curing Cancer: Patient Data Isn’t Shared By Richard G. Haermesh and Kathy Giusti | Harvard Business Review | Noember 28, 2016 | See Original Here Scientific efforts to find cures for cancer will be severely hampered if the scientific community does not change the ways in which patient data is collected, shared,…
Continue Reading »

A ‘built-in genetic circuit’ could fight cancer by starving tumors of oxygen

A ‘built-in genetic circuit’ could fight cancer by starving tumors of oxygen By Luke Dormehl — November 25, 2016 2:02 PM - - See Original Here Imagine having cells in your body that can actively repel cancer in a way that makes it theoretically impossible for you to suffer from it. Researchers at the ’s University…
Continue Reading »

Metastatic rhabdomyosarcoma initially diagnosed on the bone marrow

Metastatic rhabdomyosarcoma initially diagnosed on the bone marrow Andrés E. Quesada and Rashmi Kanagal-Shamanna | Blood 2016 128:2189; | See Original Here A 15-year-old boy presented with a rapid-onset right-sided facial mass, thrombocytopenia (114 × 109/L), and elevated serum lactate dehydrogenase. A computed tomography scan demonstrated a maxillary sinus and nasopharyngeal mass with extensive cervical lymphadenopathy. Bone…
Continue Reading »

Novel microRNA Regulatory Network Has Important Therapeutic Implications in Rhabdomyosarcoma

Novel microRNA Regulatory Network Has Important Therapeutic Implications in Rhabdomyosarcoma Interview with: Riccardo Taulli, PhD Assistant Professor of Biochemistry Dept. of Oncology, University of Turin Via Santena 5, 10126 Torino, Italy : What is the background for this study? Response: Rhabdomyosarcoma is a muscle-derived pediatric cancer for which therapeutic options have not improved significantly over…
Continue Reading »

Researchers develop algorithm to find precise cancer treatments

Researchers develop algorithm to find precise cancer treatments August 10, 2016 | eCancerNews | See Original Here University of Hawai'i Cancer Center researchers developed a computational algorithm to analyse "Big Data" obtained from tumour samples to better understand and treat cancer. "A growing problem in cancer research is figuring out how to analyse the many…
Continue Reading »

Selinexor Shows Promise in Phase I Sarcoma Trial

Selinexor Shows Promise in Phase I Sarcoma Trial Dave Levitan | July 26, 2016 | CancerNetwork | See Original Here A phase I trial of selinexor, an inhibitor of the nuclear export compound exportin 1 (XPO1), found the drug was reasonably well tolerated and showed some activity in patients with advanced soft-tissue or bone sarcoma…
Continue Reading »
Skip to toolbar